NCT06624189View on ClinicalTrials.gov

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Enrolling by invitationOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

April 24, 2026

Study Completion Date

July 24, 2026

Conditions

Hepatocellular CarcinomaCirrhosis

Interventions

OTHER

Auto-pended bot liver ultrasound order

This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors

lead

NYU Langone Health

OTHER